News & Analysis as of

Pfizer Food and Drug Administration (FDA) Federal Trade Commission (FTC)

Goodwin

Antitrust and Competition Life Sciences Quarterly Update Q2 2024

Goodwin on

To date, 2024 has not yet seen the type of mega-merger (Pfizer/Seagen) or level of agency enforcement (Sanofi/Maze or Amgen/Horizon) as 2023. But two notable investigations — one still active — show the Federal Trade...more

Faegre Drinker Biddle & Reath LLP

COVID-19 Weekly Newsletter: Positive Developments in the Race for a COVID-19 Vaccine

Positive news is emerging on the vaccine front in the fight against COVID-19, as one vaccine candidate is reported to have prevented more than 90% of symptomatic infections in clinical trials, and another was granted a Fast...more

Hogan Lovells

Coronavirus: The Hill and the Headlines – COVID-19 D.C. Update – September 2020 # 13

Hogan Lovells on

In Washington - Trump health administration officials testified Wednesday before the Senate Health, Education, Labor, and Pensions Committee on the nation's response to the COVID-19 pandemic. Dr. Anthony Fauci of the NIH,...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide